A novel <i>CEP57</i> gene mutation in mosaic variegated aneuploidy syndrome 2: case report
This report describes a novel homozygous variant of <i>CEP57</i>, expanding the clinical and genetic spectrum of MVA2 syndrome. Although, karyotype should be firstly requested if MVA is suspected, whole exome sequencing is crucial. Growth hormone therapy shows limited response in this syndrome, and the association with cancer predisposition should be further studied.
Authors
- Edurne Novella-Maestre
- Berta Diago García
- Mercè Borràs (ORCID: https://orcid.org/0000-0002-7498-4773)
- Maria Leticia Vazquez Alvarez
- Cristina Pellicer Viudes
- Purificación Marín Reina
- Paula Guzmán Tena
- Dolores Tío Guillamón
- Armando Carlos Maruenda Jiménez
- Victoria Cañadas Olmo
- María Amparo Edo Tena
- Susana Enrique Madrid
Institutions
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitario del Vinalopó (ES)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1515/jpem-2025-0643
- Primary Topic
- Genetic Syndromes and Imprinting
- Type
- article
- Field-Weighted Citation Impact
- 0.00